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Introduction 
Sepsis ,  a  l i fe- threatening organ 
dysfunction due to a dysregulated host 
response to an infection (1), is the major 
cause of mortality from any infectious 
disease worldwide (2).  The global 
epidemiological burden of sepsis is difficult 
to ascertain, however, estimates report 
that it affects every year more than 30 
million people worldwide, leading to 
6 million deaths (http://www.who.int/
sepsis/en/). Unfortunately, partly due to 
the ageing population, the increased use 
of immunosuppressive drugs and antibiotic 
resistance, the incidence of sepsis continues 
to rise (3). Around 70% of sepsis cases are 
community-acquired (4), but sepsis may 
also be the result of a healthcare associated 
infection (HAI): the most frequent adverse 
events during care delivery. In Europe, about 
80,000 hospitalized patients are estimated to 
have at least one HAI on any given day (5) 
and in high-income countries about 30% of 
patients in Intensive Care Units (ICUs) have 
at least one such infection (6). Particularly, 
in Europe, among patients staying in an ICU 
for more than two days, 8.0% presented 
with at least one HAI (7). Approximately 
two to ten percent of hospitalized patients 
and twenty to fifty percent of critically ill 
patients will develop at least one episode 
of sepsis during their admission (8-10). 
Notably, it has been reported that median 
costs of hospitalization, median length of 
hospitalization and of ICU stay and hospital 
mortality were higher for hospital-acquired 
sepsis than for community acquired sepsis 
(11). Thus, the World Health Organization 
(WHO) response to sepsis includes efforts 
to prevent HAIs (6), especially in ICUs. 
The main aim of the present study was to 
describe the epidemiology of ICU-acquired 
sepsis and related outcomes among patients 
enrolled in the framework of the Italian 
Nosocomial Infections Surveillance in ICUs 
- SPIN-UTI project. 
Methods 
Study design
The present study was conducted in 
the framework of the SPIN-UTI project, 
established in Italy in 2005 by the Italian 
Study Group of Hospital Hygiene (GISIO) 
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of the Italian Society of Hygiene, Preventive 
Medicine and Public Health (SItI) (12-
15). The SPIN-UTI project has adopted a 
protocol based on that from the Hospitals in 
Europe Link for Infection Control through 
Surveillance (HELICS) network (16), 
subsequently updated in accordance with 
the European Centre for Disease Control 
and Prevention (ECDC) HAIICU protocol 
(17). A validation study on the SPIN-UTI 
surveillance data was also performed to 
determine the sensitivity, specificity, and 
positive and negative predictive values 
of HAI data (18). Hospital participation 
was voluntary and results were handled 
confidentially. Patients were prospectively 
included, and all data were collected 
for each patient staying longer than two 
days in the ICU. Using a web-based data 
collection procedure by four electronic 
data forms, data regarding characteristics of 
Hospitals and ICUs, patients, infections and 
associated microorganisms were collected 
(12, 13). Since 2006 at present, six editions 
of the project have been conducted. Types 
of infection under surveillance were: 
pneumonia, bloodstream infections (BSIs), 
central venous catheter-related bloodstream 
infections (CRIs) and urinary tract infections 
(UTIs). The indicators obtained from 
surveillance included cumulative incidence 
and incidence density. Starting from 2008, 
surveillance of ICU-acquired sepsis has been 
added in the SPIN-UTI protocol, as severity 
of HAIs, using the definition of sepsis of the 
Consensus Conference American College of 
Chest Physicians/Society of Critical Care 
Medicine (19). Thus, in the present study, 
results of the last five editions of the SPIN-
UTI project, from 2008 to 2017, have been 
included. Case fatality rate was computed 
as the proportion of patients who die of 
sepsis among all individuals diagnosed with 
sepsis during the study period. Mortality rate 
was calculated by dividing the number of 
deaths by the population at risk during the 
study period.
Institutional Ethics Committee clearance 
was obtained to analyze anonymously the 
data. 
Statistical analyses
Statistical analyses were performed using 
the SPSS software (version 22.0, Armonk, 
NY: IBM Corp). Descriptive statistics were 
used to characterize the population using 
frequencies, means ± standard deviations 
(SDs), median values and interquartile 
ranges (IQRs). Categorical variables were 
compared using the chi square-test, and 
continuous variables by Student’s t-test. P 
≤ 0.05 was considered significant.
Results 
During the five editions of the SPIN-UTI 
project, from 2008 to 2017, a total of 13,512 
patients admitted to 76 Italian ICUs of 55 
Hospitals were enrolled for a total of 142,190 
patient-days. A summary of patients’ 
characteristics is shown in Table 1. 
A total of 1,933 patients acquired at least 
one HAI (14.3 per 100 patients) and 3072 
HAIs were acquired during ICU stay, thus, 
the cumulative incidence of ICU-acquired 
infection was 22.7 per 100 patients and 
the incidence density was 21.6 per 1000 
patient-days. 
Data on severity of ICU-acquired 
infections were reported for 2795 HAIs of 
which 47.0% (N = 1314) were followed by 
sepsis in 832 patients (6.1% of all patients 
and 43% of infected patients). Data on 
patients with ICU-acquired sepsis were 
recorded and a summary of characteristics 
is shown in Table 1.
The cumulative incidence of ICU-
acquired sepsis was 9.7 per 100 patients 
and the incidence density was 9.2 per 1000 
patient-days. Overall, 57.0% of episodes 
was classified as sepsis, 20.5% as severe 
sepsis and 22.5% as septic shock. The 
most common type of infection leading to 
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sepsis was pneumonia (45.3%), followed 
by BSIs (31.5%), CRIs (14.8%) and UTIs 
(8.4%). Overall, the most common isolated 
microorganisms from sepsis episodes 
were Acinetobacter baumannii, Klebsiella 
pneumoniae (15.9%, each) and Pseudomonas 
aeruginosa (13.1%). 
Overall ICU mortality was 19.2%. 
Particularly, mortality was significantly 
higher in patients with HAI than in patients 
without HAI (31.4% versus 16.2%; p<0.001; 
RR: 3.091; CI95%: 2.781-3.435). Among 
infected patients, case fatality rate was 
46.0% in patients with ICU-acquired sepsis 
and 31.4% in infected patients without sepsis 
(p<0.01; RR: 1.466; CI95%: 1.304-1.649). 
The case fatality rate increased with the 
severity of sepsis, from 36.4% in patients 
with sepsis, 45.3% in patients with severe 
sepsis, to 69.3% in patients with septic 
shock (p<0.01). Mean length of ICU-stay 
was significantly higher in patients with 
ICU-acquired sepsis than in patients without 
ICU-acquired sepsis (31.2 versus 24.3 days; 
p<0.01). 
Discussion and conclusions 
In 2017, the Seventieth World Health 
Assembly underlined the lack of integrated 
approaches for the prevention and clinical 
management of sepsis and thus highlighted 
the need to improve strategies for the 
prevention of infections and sepsis. Infections 
which may lead to sepsis can often be 
prevented through appropriate hand hygiene 
and other infection prevention and control 
best practices, also in the healthcare setting 
where forms of septicaemia associated with 
Table 1 - Main characteristics of patients 
Variables* All patients Patients with ICU
-acquired sepsis
Patients 13,512 832
Males 8,690 (61.8) 509 (61.9)
Mean age in years ± SD 66 ± 16.3 63.7 ± 16.6
Median age in years (IQR) 69 (58-78) 68 (55-76)
Median SAPS II score at admission (IQR) 39 (27-54) 47 (35-59)
Trauma 490 (3.7) 68 (8.3)
Impaired immunity 740 (5.5) 78 (9.5)
Administration of antibiotics within 48 hours
of admission 
8,351 (62.6) 654 (79.5)
Type of ICU admission 
- Medical 
- Scheduled surgery 
- Unscheduled surgery 
7,083 (52.9)
3,475 (26.0)
2,833 (21.1)
450 (54.7)
100 (12.2)
273 (33.2)
Origin of patients
- Other ward of this/other hospital
- Another ICU 
- Community (home)
- Long-term care facility 
9,073 (68.2)
304 (2.3)
3,798 (28.4)
142 (1.1)
589 (71.8)
36 (4.4)
186 (22.7)
9 (1.1)
Median length of stay in ICU in days (IQR) 6 (4-11) 25 (15-40)
Mortality/Case fatality rate 2,556 (19.2) 370 (46.0)
* Categorical variables are reported as number and %. 
Abbreviations: ICU, intensive care unit; IQR, interquartile range; SAPS, Simplified Acute Physiology Score; SD, 
standard deviation.
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HAIs are often severe and hard to control 
(20). 
Many of previous studies have described 
the epidemiology of sepsis worldwide, but 
the majority of them have not differentiated 
community-acquired sepsis  (sepsis 
presenting on hospital admission) from 
healthcare-associated sepsis (sepsis with 
prior healthcare exposures) or hospital-
acquired sepsis (cases developing at a 
later point of hospitalization, as ICU-
acquired sepsis) (11). Particularly, although 
some study reported the frequency of 
sepsis secondary to HAIs, i.e. healthcare-
associated sepsis (10, 21-23), data regarding 
ICU-acquired sepsis are lacking. Our study, 
conducted using data collected during a ten 
years period within the Italian SPIN-UTI 
network, offers epidemiologic evidences 
to deepen our understanding of the Italian 
burden of ICU-acquired sepsis. 
In our study 832 patients (6.2% of those 
admitted) developed sepsis during ICU-stay, 
similar frequency (5.6%) was reported in a 
previous Italian study (8). In the European 
Sepsis Occurrence in Acutely Ill Patients 
(SOAP) study conducted to report the frequency 
of sepsis in European ICUs and to identify 
various etiological, diagnostic, therapeutic, 
and prognostic factors, it has been reported that 
during ICU-stay sepsis was acquired by 8.8% 
of patients, although variation in participating 
countries was observed (22). The present 
study confirms previous results that the site 
of infection more common was the respiratory 
one (8, 10, 22) and that Gram-negative bacilli 
predominated (10; 24-26). Particularly, A. 
baumannii, K. pneumoniae and P. aeruginosa 
accounted for 44.9% of reported isolates 
from sepsis episodes. Notably, as previously 
reported (27-30), these microorganisms are 
often multidrug resistant and associated with 
hospital outbreaks, in a way that the effective 
control and treatment of HAIs caused by 
these pathogens represent a significant 
challenge for clinicians and infection control 
professionals. 
Sepsis is a disease with a high risk of 
mortality (31). In our study a high case 
fatality rate was reported with 46% of 
patients with ICU-acquired sepsis dying 
in the ICU, rising to 69.3% in patients 
with septic shock. This finding confirms 
previous evidences that death rates increase 
stepwise according to sepsis severity (22, 
32). Furthermore, in patients with ICU-
acquired sepsis case fatality rate was higher 
than in infected patients without sepsis and 
in patients without HAIs (46.0%, 31.4% and 
16.2%, respectively), confirming previous 
results (8, 10, 22). Similarly, the length of 
ICU-stay was significantly higher in patients 
with ICU-acquired sepsis than in patients 
without sepsis (8). 
Our study provides evidence that ICU-
acquired sepsis occurs frequently in Italian 
ICU patients and is associated with a high 
case fatality rate and increased length of 
ICU-stay. However, in order to explain 
these findings further analyses are needed 
to investigate determinants of higher case 
fatality rate and of increased length of ICU-
stay in this population of ICU patients in 
order to develop preventive interventions, 
optimal treatment strategies and to reduce 
mortality. Particularly, in the framework of 
sepsis as a public health problem, strategies 
should be designed for the prevention of 
infection and/or of sepsis events, identifying 
the characteristics of individuals at high 
risk. Furthermore, the early recognition and 
treatment of sepsis together with interventions 
targeting the long-term consequences of 
sepsis are essential (33). Finally, more 
specific innovative approaches to prediction 
and treatment of sepsis should be explored 
(2), also considering the personalized 
medicine approach and the use of biomarkers 
to help stratify patients based on risk profiles 
to predict adverse clinical outcomes (34). 
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Riassunto
Epidemiologia delle sepsi acquisite in terapia inten-
siva in Italia: risultati del network SPIN-UTI
Introduzione. La sepsi rappresenta la principale causa 
di morte a seguito di una malattia infettiva in tutto il 
mondo. La sepsi può essere il risultato di un’Infezione 
Correlata all’Assistenza (ICA) specialmente nelle Unità 
di Terapia Intensiva (UTI). L’obiettivo principale del 
presente studio era di descrivere l’epidemiologia della 
sepsi e i relativi esiti nei pazienti inclusi nel Progetto 
Sorveglianza Prospettica delle Infezioni Nosocomiali 
nelle UTI - SPIN-UTI del GISIO-SItI.
Disegno dello studio. Studio prospettico multicen-
trico.
Metodi. La rete SPIN-UTI ha adottato i protocolli eu-
ropei per la sorveglianza delle ICA basata sul paziente. 
Risultati. I risultati delle cinque edizioni del progetto 
SPIN-UTI, dal 2008 al 2017, dimostrano che il 47,0% 
delle ICA hanno dato origine a sepsi in 832 pazienti. 
Complessivamente, il 57,0% degli episodi è stato classi-
ficato come sepsi, il 20,5% come sepsi grave e il 22,5% 
come shock settico. I microrganismi più frequentemente 
associati agli episodi di sepsi erano Acinetobacter bau-
mannii, Klebsiella pneumoniae e Pseudomonas aeru-
ginosa. La letalità aumentava con la gravità della sepsi 
e la durata media della degenza in terapia intensiva era 
significativamente più alta nei pazienti con sepsi rispetto 
ai pazienti senza sepsi.
Conclusioni. Lo studio fornisce evidenze che la sepsi 
acquisita nelle UTI si verifica frequentemente nelle UTI 
italiane ed è associata a letalità e all’allungamento della 
durata della degenza. Tuttavia, al fine di spiegare questi 
risultati, sono necessarie ulteriori analisi per individuare 
i determinanti degli esiti avversi nei pazienti ricoverati 
in terapia intensiva.
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